| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/09/2013 | US20130116233 Novel inhibitor compounds of phosphodiesterase type 10a |
| 05/09/2013 | US20130116229 Novel inhibitor compounds of phosphodiesterase type 10a |
| 05/09/2013 | US20130116219 Antimicrobial carboline compounds |
| 05/09/2013 | US20130115193 Hepatitis C Virus Inhibitors |
| 05/09/2013 | US20130112946 Novel heterocyclic compound and organic light-emitting device including the same |
| 05/08/2013 | EP2589595A1 Agent for treating hcv infection |
| 05/08/2013 | EP2588479A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 05/08/2013 | EP2588478A1 Azaindole derivative |
| 05/08/2013 | EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588458A1 Novel tetrahydroquinoline derivatives |
| 05/08/2013 | EP2588457A1 Pyrazolo-quinolines |
| 05/08/2013 | EP2588456A1 Novel microbiocidal dioxime ether derivatives |
| 05/08/2013 | EP2588197A1 Fused heterocyclic compounds as ion channel modulators |
| 05/08/2013 | EP2588104A1 Isoindolone m1 receptor positive allosteric modulators |
| 05/08/2013 | CN103097386A Lipidated immune response modifier compound compositions, formulations, and methods |
| 05/08/2013 | CN103097385A Ip receptor agonist heterocyclic compounds |
| 05/08/2013 | CN103097384A Substituted imidazo[1,2-a]pyrimidines and pyridines |
| 05/08/2013 | CN103097383A Pyrazoloquinoline compound |
| 05/08/2013 | CN103097382A 2-(arylamino)-3H-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as MPGES-1 inhibitors |
| 05/08/2013 | CN103097381A 1, 8-naphthyridines as kinase inhibitors |
| 05/08/2013 | CN103097375A Cyclohexyl-azetidinyl antagonists of CCR2 |
| 05/08/2013 | CN103097354A Substituted benzamide compounds |
| 05/08/2013 | CN103097352A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 05/08/2013 | CN103096977A Fused heterocyclic compounds as ion channel modulators |
| 05/08/2013 | CN103096716A Besylate salt of a BTK inhibitor |
| 05/08/2013 | CN103087106A Chirality phosphine nitrogen compound containing N-aryl as well as synthetic method and application thereof |
| 05/08/2013 | CN103087065A Ovel Heterocyclic Compound, Organic Light-emitting Device Including The Same And Flat Panel Display Device |
| 05/08/2013 | CN103087064A Method for preparing 3-aryl purrocoline derivative |
| 05/08/2013 | CN103087063A Preparation method of moxifloxacin and salts of moxifloxacin |
| 05/08/2013 | CN103087062A Method for preparing N-sulfonyl substituted tetrahydro-beta-carboline derivative |
| 05/08/2013 | CN103087061A Substituted purrocoline compound and preparation method and application thereof |
| 05/08/2013 | CN103087060A High activity paichongding isomers and preparation method thereof |
| 05/08/2013 | CN103087059A Preparation method for high-purity olprinone hydrochloride |
| 05/08/2013 | CN102295645B Synthetic method of 8-benzyl-2,8-diazabicyclo[4.3.0] nonane |
| 05/08/2013 | CN102105473B Tricyclic nitrogen containing compounds and their use as antibacterials |
| 05/08/2013 | CN101987849B Method of treatment of age-related macular degeneration(AMD) |
| 05/08/2013 | CN101921271B Pyridine [2,3-d] pyrimidone compounds and application thereof to pharmacy |
| 05/08/2013 | CN101574084B 螺二氢吲哚哌啶衍生物 Spiroindoline piperidine derivative |
| 05/07/2013 | USRE44205 Adenosine A2a receptor antagonists |
| 05/07/2013 | US8436180 Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof |
| 05/07/2013 | US8436178 Imidazoquinolines with immuno-modulating properties |
| 05/07/2013 | US8436177 Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 05/07/2013 | US8436174 (+)-morphinanium quaternary salts and processes for their production |
| 05/07/2013 | US8436029 Pharmaceutical forms, and methods of making and using the same |
| 05/07/2013 | US8436011 Pyridinopyridinone derivatives, preparation thereof and therapeutic use thereof |
| 05/07/2013 | US8435993 Methods of inhibiting metastasis from cancer |
| 05/07/2013 | US8435987 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/07/2013 | US8435986 Bicyclic traizole derivatives for treating of tumors |
| 05/07/2013 | US8435980 Pyrrolopyridine inhibitors of kinases |
| 05/07/2013 | CA2607299C Compounds and compositions as protein kinase inhibitors |
| 05/07/2013 | CA2538864C Thalidomide analogs as tnf-alpha modulators |
| 05/02/2013 | WO2013063549A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/02/2013 | WO2013063492A1 Novel compositions and methods for treating cancer |
| 05/02/2013 | WO2013061973A1 Heteroaryl sulfonamide compound or salt thereof |
| 05/02/2013 | WO2013061850A1 Organic electroluminescence element, display device, and lighting device |
| 05/02/2013 | WO2013061080A1 Anticancer pyridopyrazines via the inhibition of fgfr kinases |
| 05/02/2013 | WO2013061077A1 New compounds |
| 05/02/2013 | WO2013060881A1 Pyridopyrimidines and their therapeutic use |
| 05/02/2013 | WO2013060818A1 Novel process |
| 05/02/2013 | WO2013060636A1 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 05/02/2013 | WO2013060292A1 R-praziquantel preparation method |
| 05/02/2013 | WO2013060179A1 Acyltetrahydro-β-carboline compounds as well as derivatives, applications and preparation methods thereof |
| 05/02/2013 | WO2013060029A1 Allosteric modulators of metabotropic glutamate receptors |
| 05/02/2013 | WO2013059928A1 Hiv protease inhibitors |
| 05/02/2013 | US20130109859 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE |
| 05/02/2013 | US20130109714 Neurodegenerative disease therapeutic agent |
| 05/02/2013 | US20130109711 Novel compounds |
| 05/02/2013 | US20130109708 Chemical Compounds |
| 05/02/2013 | US20130109699 Tetrahydrocarboline derivative |
| 05/02/2013 | US20130109695 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 05/02/2013 | US20130109693 Derivatives of pyrido [3,2-d] pyrimidine, methods for preparation thereof and therapeutic uses thereof |
| 05/02/2013 | US20130109688 Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease |
| 05/02/2013 | US20130109686 Isoindolone m1 receptor positive allosteric modulators |
| 05/02/2013 | US20130109685 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 05/02/2013 | CA2853826A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/02/2013 | CA2853729A1 Novel compositions and methods for treating cancer |
| 05/02/2013 | CA2853390A1 Anticancer pyridopyrazines via the inhibition of fgfr kinases |
| 05/02/2013 | CA2853367A1 New compounds |
| 05/02/2013 | CA2852796A1 Benzoxazolinone compounds with selective activity in voltage-gated sodium channels |
| 05/01/2013 | EP2586780A1 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and use thereof |
| 05/01/2013 | EP2585463A1 Beta carboline derivatives useful in the treatment of proliferative disorders |
| 05/01/2013 | EP2585462A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 05/01/2013 | EP2585461A1 2,4- diaryl - substituted [1,8]naphthyridines as kinase inhibitors for use against cancer |
| 05/01/2013 | EP2585460A1 Quinolizidine and indolizidine derivatives |
| 05/01/2013 | EP2585439A1 Heterocyclic compounds, their preparation and their therapeutic application |
| 05/01/2013 | CN103081155A Light-emitting element |
| 05/01/2013 | CN103081149A Organic semiconductor particulate material, organic semiconductor thin-film, dispersion liquid for forming organic semiconductor film, method for producing organic semiconductor thin-film, and organic thin-film transistor |
| 05/01/2013 | CN103080112A Indolizine derivatives, process for the preparation thereof and therapeutic use thereof |
| 05/01/2013 | CN103080111A Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof |
| 05/01/2013 | CN103080110A Method for the production of 5-fluoro-1h-pyrazolo[3,4-b]pyridine-3-carbonitrile |
| 05/01/2013 | CN103080109A Deuterium-enriched heterocyclic compounds as kinase inhibitors |
| 05/01/2013 | CN103080108A Pyridyl-amine fused azadecalin modulators |
| 05/01/2013 | CN103080092A Pyrazolo-quinolines |
| 05/01/2013 | CN103080088A Production method of intermediate compound for synthesizing medicament |
| 05/01/2013 | CN103079566A Heterocyclyl compounds as histamine H3 receptor ligands |
| 05/01/2013 | CN103073615A Oleanolic acid kushenin compound salt and preparation method thereof |
| 05/01/2013 | CN103073570A Moxifloxacin and salt intermediate thereof and preparation methods thereof |
| 05/01/2013 | CN103073548A Preparation method for 6-tert-butyl-3-ethyl-4, 5-dihydro-1H-pyrazolo-[3, 4-c] pyridine-3, -6 (7H)-dicarboxylic acid diester |
| 05/01/2013 | CN103073547A Synthesis method of (3aS, 9bR)-tert-butyl-3,3 a, 4,5-tetrahydro-pyrrolo [3,4-c] quinolin-2 (9bH) ester |
| 05/01/2013 | CN103073546A Preparation method of mebhydrolin napadisylate |